A Phase 1 Study To Evaluate The Safety, Tolerability, And Pharmacokinetics Of PNU-100480 (PF-02341272) After First Time Administration Of Ascending Oral Doses To Healthy Adult Subjects Under Fed And Fasted Conditions.
Phase of Trial: Phase I
Latest Information Update: 26 Aug 2013
At a glance
- Drugs Sutezolid (Primary)
- Indications Tuberculosis
- Focus Adverse reactions; Pharmacokinetics
- 08 Oct 2009 Actual number of patients (19) as reported by ClinicalTrials.gov.
- 08 Oct 2009 Status changed from active, no longer recruiting to completed as reported by ClinicalTrials.gov.
- 23 Jun 2009 Status changed from recruiting to active, no longer recruiting as reported by ClinicalTrials.gov.